SEC Form 5 · accession 0001185185-17-001120
IGC Pharma, Inc. · IGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard K Prins
Director
Period of report
Mar 31, 2017
Accepted (ET)
May 11, 2017 · 8:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326205
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Dec 23, 2016 | G | 2,000 | $0.00 | D | 387,000 | D | |
| Common stock | Dec 30, 2016 | G | 2,000 | $0.00 | D | 385,000 | D | |
| Common stock | Jan 6, 2017 | G | 2,000 | $0.00 | D | 383,000 | D | |
| Common stock | Jan 13, 2017 | G | 2,000 | $0.00 | D | 381,000 | D | |
| Common stock | Jan 23, 2017 | G | 2,000 | $0.00 | D | 379,000 | D | |
| Common stock | Jan 27, 2017 | G | 2,000 | $0.00 | D | 377,000 | D | |
| Common stock | Feb 3, 2017 | G | 2,000 | $0.00 | D | 375,000 | D | |
| Common stock | Feb 10, 2017 | G | 2,000 | $0.00 | D | 373,000 | D | |
| Common stock | Feb 17, 2017 | G | 2,000 | $0.00 | D | 371,000 | D | |
| Common stock | Feb 24, 2017 | G | 2,000 | $0.00 | D | 369,000 | D | |
| Common stock | Mar 3, 2017 | G | 2,000 | $0.00 | D | 367,000 | D | |
| Common stock | Mar 10, 2017 | G | 2,000 | $0.00 | D | 365,000 | D | |
| Common stock | Mar 17, 2017 | G | 2,000 | $0.00 | D | 363,000 | D | |
| Common stock | Mar 27, 2017 | G | 2,000 | $0.00 | D | 361,000 | D | |
| Common stock | Mar 31, 2017 | G | 2,000 | $0.00 | D | 359,000 | D | |
| Common stock | Apr 7, 2017 | G | 2,000 | $0.00 | D | 357,000 | D | |
| Common stock | Apr 14, 2017 | G | 2,000 | $0.00 | D | 355,000 | D | |
| Common stock | Apr 21, 2017 | G | 2,000 | $0.00 | D | 353,000 | D | |
| Common stock | Apr 28, 2017 | G | 2,000 | $0.00 | D | 351,000 | D | |
| Common stock | May 5, 2017 | G | 2,000 | $0.00 | D | 349,000 | D |
Table II — derivative securities
No Table II lines on this filing.